The presence of an extractable substance in the CSF of humans with cerebral vasospasm after subarachnoid haemorrhage that correlates with phosphatase inhibition

Biochimica et Biophysica Acta - General Subjects

Volumn 1474, Issue 3, 2000, Pages 283-290

  Pyne, Gail J ^a   Cadoux Hudson, Thomas A D ^a   Clark, Joseph F ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Contraction; Relaxation; Vascular smooth muscle; Vasospasm

Indexed keywords

ENZYME INHIBITOR; MYOSIN LIGHT CHAIN; OKADAIC ACID; PHOSPHATASE;

ANIMAL TISSUE; ARTICLE; BRAIN VASOSPASM; CAROTID ARTERY; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME INHIBITION; HUMAN; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; SWINE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

ANIMALS; CAROTID ARTERIES; ENZYME INHIBITORS; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOSIN LIGHT CHAINS; OKADAIC ACID; OXYGEN CONSUMPTION; PHOSPHOPROTEIN PHOSPHATASE; SUBARACHNOID HEMORRHAGE; SWINE; VASODILATION; VASOSPASM, INTRACRANIAL;

SUIDAE;

EID: 0034193704     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(00)00030-1     Document Type: Article

References (52)

1. Cadoux-Hudson T.A.D., Pyne G.J., Clark J.F. Subarachnoid haemorrhage induced cerebral vasospasm: A subcellular perspective on the control of tension. Emerging Ther. Targets. 3:1999;439-452.
2. Gailly P., Wu X., Haystead T.A.J., Somlyo A.P., Cohen P.T.W., Cohen P., Somlyo A.V. Regions of the 110-kDa regulatory subunit M110 required for regulation of myosin light chain phosphatase activity in smooth muscle. Eur. J. Biochem. 239:1996;326-332.
3. Alessi D., MacDougall L.K., Sola M.M., Ikebe M., Cohen P. The control of protein phosphatase-1 by targetting subunits. Eur. J. Biochem. 210:1992;1023-1035.
4. Mitsui T., Inagaki M., Ikebe M. Purification and characterisation of smooth muscle myosin-associated phosphatase from chicken gizzards. J. Biol. Chem. 267:1992;16727-16735.
5. Nowak G., Rainer F., Sobieszek A. Purification and characterisation of the myofibrillar form of myosin light-chain phosphatase from turkey gizzard smooth muscle. Biochim. Biophys. Acta. 1203:1993;230-235.
6. Werth D.K., Haeberle J.R., Hathaway D.R. Purification of a myosin phosphatase from bovine aortic smooth muscle. J. Biol. Chem. 257:1982;7306-7309.
7. DiSalvo J., Gifford D., Kokkinakis A. Adv. Enzyme Regul. 23:1985;103-122.
8. Macdonald R.L., Weir B.K.A., Grace M.G.A., Chen M.H., Martin T.P., Young J.D. Mechanism of cerebral vasospasm following subarachnoid hemorrhage in monkeys. Can. J. Neurol. Sci. 19:1992;419-427.
9. Macdonald R.L., Wallace M.C., Coyne T.J. J. Neurosurg. 80:1994;433-439.
10. Shigeno T., Clozel M., Sakai S., Saito A., Goto K. The effect of bosentan, a new potent endothelin receptor antagonist, on the pathogenesis of cerebral vasospasm. Neurosurgery. 37:1995;87-91.
11. Varsos V., Liszczak T.M., Hee Lan D., Kistler J.P., Vielma J., McL. Black P., Heros R.C., Zervas N.T. Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine or papaverine in a 'two-hemorrhage' canine model. J. Neurosurg. 58:1983;11-17.
12. Zuccarello M., Soattin G.B., Lewis A.I., Breu V., Hallak H., Rapoport R.M. Prevention of subarachnoid haemorrhage induced vasospasm by oral administration of endothelin receptor antagonists. J. Neurosurg. 84:1996;503-507.
13. Cook D.A. Mechanisms of cerebral vasospasm in subarachnoid haemorrhage. Pharmacol. Ther. 66:1995;259-284.
14. Butler W.E., Peterson J.W., Zervas N.T., Morgan K.G. Intracellular calcium, myosin light chain phosphorylation and contractile force in experimental cerebral vasospasm. Neurosurgery. 38:1996;781-788.
15. Fisher C.M., Kistler J.P., Davis J.M. Relation of cerebral vasospasm to subarachnoid haemorrhage visualized by computer tomographic scanning. Neurosurgery. 6:1980;1-9.
16. Weir B., Grace M., Hansen J., Rothberg C. Time course of vasospasm in man. J. Neurosurg. 48:1978;173-178.
17. Buckell M. Demonstration of substances capable of contracting smooth muscle in haematoma fluid from certain cases of ruptured cerebral aneurysm. J. Neurol. Neurosurg. Psychiatry. 27:1964;198-199.
18. Boullin D.J., Mohan J., Grahame-Smith D.G. Evidence for the presence of a vasoactive substance (possibly involved in the aetiology of cerebral arterial spasm) in cerebrospinal fluid from patients with subarachnoid haemorrhage. J. Neurol. Neurosurg. Psychiatry. 39:1976;756-766.
19. Honda M., Terao H. Experimental vasospasm produced without blood cell components - hypothesis for the development of cerebral vasospasm. Neurol. Med. Chir. (Tokyo). 37:1997;373-378.
20. Kim P., Yoshimoto Y., Iino M., Tomio S., Kirino T., Nonomura Y. Impaired calcium regulation of smooth muscle during chronic vasospasm following subarachnoid haemorrhage. J. Cereb. Blood Flow Metab. 16:1996;334-341.
21. Linder M. Inhibition by dipyridamole of cerebral vasospasm induced in vitro by whole blood. J. Neurosurg. 58:1983;352-355.
22. Weir B. The pathophysiology of cerebral vasospasm. Br. J. Neurosurg. 9:1995;375-390.
23. Yakubu M.A., Leffler C.W. Role of endothelin-1 in cerebral hematoma-induced modification of cerebral vascular reactivity in piglets. Brain Res. 734:1996;149-156.
24. Shiota T., Bernanke D.H., Parent A.D., Hasui K. Protein kinase C has two different major roles in lattice compaction enhanced by cerebrospinal fluid from patients with subarachnoid haemorrhage. Stroke. 27:1996;1889-1895.
25. Matsui T., Takuwa Y., Joshita H., Yamashita K., Asano T. Possible role of protein kinase C-dependent smooth muscle contraction in the pathogenesis of chronic cerebral vasospasm. J. Cereb. Blood Flow Metab. 11:1991;143-149.
26. Watanabe T., Asano T., Shimizu T., Seyama Y., Takakura K. Participation of lipooxygenase products from arachidonic acid in the pathogenesis of cerebral vasospasm. J. Neurochem. 50:1988;1145-1150.
27. Zhang H., Cook D. Cerebral vascular smooth muscle potassium channels and their possible role in the management of vasospasm. Pharmacol. Toxicol. 75:1994;327-336.
28. Harada T., Seto M., Sasaki Y., London S., Luo Z., Mayberg M. The time course of myosin light chain phosphorylation in blood induced vasospasm. Neurosurgery. 36:1995;1178-1183.
29. Bearchell M.C., Redman C.W.G., Pyne G.J., Cadoux-Hudson T.A.D., Clark J.F. Am. J. Obstet. Gynecol. 179:1998;1534-1536.
30. Dillon P.F., Murphy R.A. Tonic force maintenance with reduced shortening velocity in arterial smooth muscle. Am. J. Physiol. 242:(Cell Physiol. 11):1982;C102-C108.
31. Kemp B.E., Pearson R.B. Spatial requirements for location of basic residues in peptide substrates for smooth muscle myosin light chain kinase. J. Biol. Chem. 260:1985;3355-3359.
32. Ngai P.K., Carruthers C.A., Walsh M.P. Isolation of the native form of chicken gizzard myosin light-chain kinase. Biochem. J. 218:1984;863-870.
33. Pato M.D., Kerc E. Purification of smooth muscle myosin phosphatase from turkey gizzard. Methods Enzymol. 159:1988;446-453.
34. Ishikawa T., Chijiwa T., Hagiwara M., Mamiya S., Saitoh M., Hidaka H. ML-9 inhibits the vascular contraction via the inhibition of myosin light chain phosphorylation. Mol. Pharmacol. 33:1988;598-603.
35. Karczewski P., Bartel S., Krause E.-G. Protein phosphorylation in the regulation of cardiac contractility and vascular smooth muscle tone. Curr. Opin. Nephrol. Hypertens. 2:1993;33-40.
36. Ito M., Hartshorne D.J. Phosphorylation of myosin as a regulatory mechanism in smooth muscle. Front. Smooth Muscle Res. 327:1990;57-72.
37. M. Barany, K. Barany, in: M. Barany (Ed.), Biochemistry of Smooth Muscle Contraction, Vol. 1, Academic Press, San Diego, CA, 1996, pp. 321-339.
38. Barany M., Polyak E., Barany K. Protein phosphorylation during the contraction-relaxation-contraction cycle of arterial smooth muscle. Arch. Biochem. Biophys. 294:1992;571-578.
39. Zhang Y., Moreland S., Moreland R.S. Regulation of vascular smooth muscle contraction; myosin light chain phosphorylation dependent and independent pathways. Can. J. Physiol. Pharmacol. 72:1993;1386-1391.
40. Cohen P., Klumpp S., Schelling D.L. An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues. FEBS Lett. 250:1989;596-600.
41. Dillon P.F., Aksoy M.O., Driska S.P., Murphy R.A. Myosin phosphorylation and the cross bridge cycle in arterial smooth muscle. Science. 211:1981;495-497.
42. Driska S.P., Aksoy M.O., Murphy R.A. Myosin light chain phosphorylation associated with contraction in arterial smooth muscle. Am. J. Physiol. 240:(Cell Physiol. 9):1981;C222-C233.
43. Somlyo A.P., Somlyo A.V. Signal transduction and regulation in smooth muscle. Nature. 372:1994;231-236.
44. Somlyo A.P. J. Physiol. 516:1999;630.
45. Fukami M., Tani E., Takai A., Yamaura I., Minami N. Stroke. 26:1995;2321-2327.
46. Ohta S., Nishihara J., Oka Y., Todo H., Kumon Y., Sakaki S. Possible mechanism to induce protein kinase C-dependent arterial smooth muscle contraction after subarachnoid haemorrhage. Acta Neurochir. 137:1995;217-225.
47. Takahashi K., Nadal-Ginard B. Molecular cloning and sequence analysis of smooth muscle calponin. J. Biol. Chem. 266:1991;13284-13288.
48. Winder S.J., Walsh M.P. Calponin, thin filament-linked regulation of smooth muscle contraction. Cell Signall. 5:1993;677-686.
49. Winder S.J., Walsh M.P. Smooth muscle calponin. Inhibition of actomyosin MgATPase and regulation by phosphorylation. J. Biol. Chem. 265:1990;10148-10155.
50. Eto M., Ohmori T., Suziki M., Furuya K., Morita F. A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C, isolation from porcine aorta media and characterisation. J. Biochem. 118:1995;1104-1107.
51. Paul R.J., Hardin C., Campbell J., Raeymaekers L. Compartmentation of metabolism and function in smooth muscle. Muscle Energ. 315:1989;381-390.
52. Hughes J.T., Schianchi P.M. Cerebral artery spasm. J. Neurosurg. 48:1978;515-525.